As cannabis research continues to evolve, one of the most compelling areas of study examines how cannabinoids interact with cancer cells. A landmark review published in the Journal of Cancer Research and Clinical Oncology analyzed over five decades of peer-reviewed research to paint a comprehensive picture of cannabinoids’ potential role in oncology.
The Growing Body of Evidence
Cannabis has been used medicinally for thousands of years, but it’s only in recent decades that scientists have begun to understand why it works. The research team behind this extensive review examined peer-reviewed articles published between January 1970 and April 2021, searching databases including Google Scholar, MEDLINE, PubMed, and Web of Science.
Their findings? Phyto-, endogenous, and synthetic cannabinoids all demonstrated antitumor effects in both laboratory (in vitro) and animal (in vivo) studies. Howeverโand this is crucialโthese effects depend on several factors including the type of cancer, the concentration of cannabinoids used, and how many receptor targets are present in the tissue.
Understanding the Endocannabinoid System
To understand how cannabinoids might affect cancer, we first need to understand the endocannabinoid system (ECS). This biological system exists in all mammals and consists of cannabinoid receptors, endogenous cannabinoids (cannabinoids your body naturally produces), and enzymes that synthesize and break down these compounds.
The two primary cannabinoid receptors are:
- CB1 Receptors: Predominantly found in the central nervous system and brain
- CB2 Receptors: Primarily located in immune cells and peripheral tissues
But the research reveals something fascinating: cannabinoids don’t just work through CB1 and CB2. Scientists have discovered activity through additional pathways including GPR55, TRPM8, TRPA1, TRPV1, and TRPV2 ion channels. This multi-pathway activity may explain why cannabinoids show such diverse effects across different cancer types.
The Cannabinoid Roster: More Than Just THC and CBD
When most people think of cannabis compounds, they think of THC and CBD. But the cannabis plant is remarkably complexโmore than 120 phytocannabinoids have been isolated from Cannabis sativa L., classified into eleven distinct chemical subtypes.
The major cannabinoids studied in cancer research include:
- ฮ9-THC (Delta-9-Tetrahydrocannabinol): The primary psychoactive compound, extensively studied for its anticancer properties
- CBD (Cannabidiol): Non-psychoactive compound showing promise across multiple cancer types
- CBG (Cannabigerol): Often called the “mother cannabinoid,” gaining attention for unique properties
- CBC (Cannabichromene): Non-psychoactive with emerging research interest
- CBN (Cannabinol): A degradation product of THC with its own therapeutic potential
Researchers are also increasingly interested in acidic cannabinoids (like THCA and CBDA) and varinic cannabinoids (like THCV and CBDV), which may offer unique therapeutic benefits.
How Cannabinoids May Fight Cancer: The Mechanisms
The research identifies several mechanisms through which cannabinoids demonstrate antitumor activity:
1. Apoptosis Induction
Apoptosis is programmed cell deathโa natural process that helps eliminate damaged or abnormal cells. Cancer cells often evade apoptosis, allowing them to grow unchecked. Studies show cannabinoids can trigger apoptosis specifically in cancer cells while generally leaving healthy cells unharmed.
2. Anti-Proliferation Effects
Cannabinoids have demonstrated the ability to slow or stop cancer cell division, effectively putting the brakes on tumor growth.
3. Anti-Angiogenesis
Tumors need blood vessels to grow. Some cannabinoids appear to inhibit angiogenesisโthe formation of new blood vessels that tumors need for nutrients and oxygen.
4. Anti-Metastatic Properties
Perhaps most significantly, certain cannabinoids show potential in reducing cancer cell migration and invasion, which could help prevent metastasisโthe spread of cancer to other parts of the body.
The Entourage Effect in Cancer Research
One of the most intriguing findings in cannabinoid research is the entourage effectโthe theory that cannabis compounds work better together than in isolation. Recent studies have shown that combining CBD with THC can produce enhanced therapeutic outcomes compared to either compound alone.
This synergistic relationship extends beyond cannabinoids to include terpenesโthe aromatic compounds that give cannabis its distinctive scents. Terpenes like limonene, myrcene, and beta-caryophyllene may enhance the therapeutic effects of cannabinoids while adding their own potential benefits.
Current Clinical Applications
While much of the anticancer research remains in preclinical stages, cannabinoids already have established roles in cancer care:
- Chemotherapy-Induced Nausea and Vomiting: FDA-approved synthetic cannabinoids (dronabinol and nabilone) are prescribed for this purpose
- Appetite Stimulation: Helping patients maintain nutrition during treatment
- Pain Management: Particularly for chronic cancer-related pain
- Anxiety and Sleep: Improving quality of life during cancer treatment
The American Society of Clinical Oncology (ASCO) has acknowledged the growing interest in cannabinoids and published guidelines for oncologists discussing these options with patients.
Important Considerations
The researchers emphasize several crucial points:
Cancer Type Matters: Different cancers respond differently to cannabinoids. What works in breast cancer cells may not work the same way in lung or colon cancer cells.
Dosage is Critical: The concentration of cannabinoids significantly affects outcomes. Laboratory studies often use concentrations that may not translate directly to human dosing.
More Human Trials Needed: While preclinical results are promising, large-scale human clinical trials are essential before drawing definitive conclusions about anticancer applications.
Quality and Consistency: Variability in cannabinoid concentrations and quality across products can affect therapeutic outcomes, highlighting the importance of obtaining cannabis from reputable, tested sources.
The Future of Cannabinoid Cancer Research
The research landscape is rapidly evolving. Clinical trials like the CAFCARS trial are specifically investigating cannabis extracts for managing cancer-related symptoms. Scientists are exploring:
- Combination therapies pairing cannabinoids with traditional chemotherapy
- Nanotechnology-based delivery systems for targeted cannabinoid treatment
- Personalized approaches based on tumor receptor profiles
- The role of the endocannabinoid system in cancer development and progression
What This Means for Cannabis Consumers
If you’re interested in the potential wellness benefits of cannabinoids, here’s what to keep in mind:
Education is Key: Understanding the difference between various cannabinoids and their potential effects empowers you to make informed decisions.
Quality Matters: Look for products that have been third-party tested for potency and purity. At Vibe By California, all our products undergo rigorous testing to ensure consistency and quality.
Consult Healthcare Providers: If you’re considering cannabis as part of any health regimenโespecially if you’re dealing with a serious medical conditionโtalk to your healthcare provider first.
Full-Spectrum Products: Given the research on the entourage effect, full-spectrum products containing multiple cannabinoids and terpenes may offer advantages over isolated compounds.
The Bottom Line
The research reviewed in the Journal of Cancer Research and Clinical Oncology represents a significant milestone in our understanding of cannabinoids’ potential role in oncology. While we’re not yet at the point of prescribing cannabis as a cancer treatment, the scientific foundation is being builtโone peer-reviewed study at a time.
What’s clear is that cannabinoids are far more than recreational substances. They’re complex compounds with intricate mechanisms of action that scientists are only beginning to fully understand. As research continues and clinical trials progress, we may see cannabinoids become an established part of the oncological toolkit.
Until then, the best approach is staying informed, consulting with healthcare professionals, and choosing high-quality, tested cannabis products from trusted sources.
Disclaimer: This article is for educational purposes only and does not constitute medical advice. Cannabis is not approved by the FDA for the treatment of cancer. If you are dealing with cancer or any serious medical condition, please consult with qualified healthcare providers. The research discussed represents preclinical and early clinical findings that require further study.
Source: Mangal, N., Erridge, S., Habib, N., Sadanandam, A., Reebye, V., & Sodergren, M. H. (2021). Cannabinoids in the landscape of cancer. Journal of Cancer Research and Clinical Oncology, 147, 2507โ2534. https://doi.org/10.1007/s00432-021-03710-7
Explore Cannabis at Vibe By California
Curious about the cannabinoids discussed in this article? Our knowledgeable budtenders can help you explore products featuring THC, CBD, CBG, and more. Visit any of our California or Oregon locations, or shop online to discover premium, tested cannabis products.
